Compare HUT & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HUT | SNN |
|---|---|---|
| Founded | 2011 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | 16988 |
| Industry | Finance: Consumer Services | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 14.3B |
| IPO Year | 2023 | N/A |
| Metric | HUT | SNN |
|---|---|---|
| Price | $120.67 | $29.89 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 2 |
| Target Price | ★ $65.20 | $36.25 |
| AVG Volume (30 Days) | ★ 3.7M | 1.1M |
| Earning Date | 05-06-2026 | 03-16-2026 |
| Dividend Yield | N/A | ★ 2.48% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $235,118,000.00 | N/A |
| Revenue This Year | $161.69 | $8.58 |
| Revenue Next Year | N/A | $5.60 |
| P/E Ratio | ★ N/A | $64.97 |
| Revenue Growth | ★ 44.79 | N/A |
| 52 Week Low | $17.87 | $29.08 |
| 52 Week High | $140.80 | $38.79 |
| Indicator | HUT | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 56.44 | 45.14 |
| Support Level | $39.84 | $29.10 |
| Resistance Level | $140.80 | $31.28 |
| Average True Range (ATR) | 10.50 | 0.46 |
| MACD | -1.43 | -0.00 |
| Stochastic Oscillator | 65.55 | 26.54 |
Hut 8 Corp is an energy infrastructure platform that integrates power, digital infrastructure, and compute at scale to fuel next-generation, energy-intensive use cases. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.